These results collectively indicate that hydroxyasiaticoside noticeably inhibits the expression levels of TNF-α and IL-6, and simultaneously improves schistosomiasis-induced liver fibrosis by regulating inflammatory response factors in vivo. Here, IL6 is linked to schistosomiasis.